Regeneron Pharmaceuticals Intellectual Property Contracts & Agreements

22 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
First Amendment to Amended and Restated License and Collaboration Agreement between Regeneron Pharmaceuticals, Inc. and Aventis Pharmaceuticals Inc.
License Agreements
Regeneron Pharmaceuticals
Biotechnology
2023
Fifth Amendment to Amended and Restated License and Collaboration Agreement between Sanofi and Regeneron
License Agreements
Regeneron Pharmaceuticals
Biotechnology
2022
Amended and Restated Immuno-Oncology License and Collaboration Agreement between Sanofi Biotechnology SAS and Regeneron Pharmaceuticals, Inc.
License Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2022
Fourth Amendment to Amended and Restated License and Collaboration Agreement between Sanofi and Regeneron Pharmaceuticals, Inc.
License Agreements
Regeneron Pharmaceuticals
Biotechnology
2022
License Agreement among Regeneron Pharmaceuticals, F. Hoffmann-La Roche Ltd, and Genentech, Inc. (August 18, 2020)
License Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2020
Praluent Cross License and Commercialization Agreement between Sanofi Biotechnology SAS and Regeneron Pharmaceuticals, Inc.
License Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2020
Third Amendment to Amended and Restated License and Collaboration Agreement between Sanofi and Regeneron
License Agreements
Regeneron Pharmaceuticals
Biotechnology
2020
License Agreement between Alnylam Pharmaceuticals, Inc. and Regeneron Pharmaceuticals, Inc.
License Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2019
ANG2 License and Collaboration Agreement between Bayer Healthcare LLC and Regeneron Pharmaceuticals, Inc. (March 23, 2016)
License Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2016
Non-Exclusive License and Settlement Agreement among Genentech, Regeneron, and Sanofi (May 17, 2013)
License Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2013
Amended and Restated Non-Exclusive License and Settlement Agreement between Genentech, Inc. and Regeneron Pharmaceuticals, Inc.
License Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2013
First Amendment to Amended and Restated License and Collaboration Agreement between Regeneron Pharmaceuticals, Inc. and Aventis Pharmaceuticals Inc. (Sanofi)
License Agreements
Regeneron Pharmaceuticals
Biotechnology
2013
Non-Exclusive License and Partial Settlement Agreement between Genentech, Inc. and Regeneron Pharmaceuticals, Inc.
License Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2012
Amendment to Non-Exclusive License and Material Transfer Agreement between Astellas Pharma Inc. and Regeneron Pharmaceuticals, Inc.
License Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2010
Amended and Restated License and Collaboration Agreement among Aventis Pharmaceuticals Inc., Sanofi-Aventis Amerique du Nord, and Regeneron Pharmaceuticals, Inc.
License Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2010
Amended and Restated Non-Exclusive License Agreement between Cellectis and Regeneron Pharmaceuticals, Inc.
License Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2008
License and Collaboration Agreement among Aventis Pharmaceuticals Inc., Sanofi-Aventis Amerique du Nord, and Regeneron Pharmaceuticals, Inc. (November 28, 2007)
License Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2008
Non-Exclusive License and Material Transfer Agreement between Astellas Pharma Inc. and Regeneron Pharmaceuticals, Inc.
License Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2007
Non-Exclusive License and Material Transfer Agreement between AstraZeneca UK Limited and Regeneron Pharmaceuticals, Inc.
License Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2007
License and Collaboration Agreement between Bayer HealthCare LLC and Regeneron Pharmaceuticals, Inc. (October 18, 2006)
License Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2006
Non-Exclusive Patent License Agreement between Merck & Co., Inc. and Regeneron Pharmaceuticals, Inc.
License Agreements
Regeneron Pharmaceuticals
Biotechnology
NJ
2003
IL-1 License Agreement among Regeneron Pharmaceuticals, Immunex Corporation, and Amgen Inc. dated June 26, 2002
License Agreements
Regeneron Pharmaceuticals
Biotechnology
DE
2002